Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer

NCT03621904 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT03621904
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03621904 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PROMOTE Study: Prediction of Response Of HorMOnal Treatment in Advanced and Recurrent Endometrial Cancer
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
October 15, 2022
Completion date
September 1, 2027
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endometrial cancer recurrent, endometrial cancer stage iii, endometrial cancer stage iv